Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission

NCT03376477 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped loss of funding

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: GM-CSF vaccine
DRUG: Lenalidomide
DRUG: Prevnar13
OTHER: Placebo Prevnar13
OTHER: Placebo GM-CSF Vaccine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]